Scavenger receptor class B type 1 protein (SCARB1) plays an essential role in cholesterol homeostasis and functions in binding high density lipoprotein cholesterol (HDL) in liver and other tissues of the body. SCARB1 also functions in lymphocyte homeostasis and in the uptake of hepatitis C virus (HCV) by the liver. A genetic deficiency of this protein results in autoimmune disorders and significant changes in blood cholesterol phenotype. Comparative SCARB1 amino acid sequences and structures and SCARB1 gene locations were examined using data from several vertebrate genome projects. Vertebrate SCARB1 sequences shared 50%-99% identity as compared with 28%-31% sequence identities with other CD36-like superfamily members, ie, SCARB2 and SCARB3 (also called CD36). At least eight N-glycosylation sites were conserved among most of the vertebrate SCARB1 proteins examined. Sequence alignments, key amino acid residues, and conserved predicted secondary structures were also studied, including: cytoplasmic, transmembrane, and exoplasmic sequences; conserved N-terminal and C-terminal transmembrane glycines which participate in oligomer formation; conserved cystine disulfides and a free SH residue which participates in lipid transport; carboxyl terminal PDZbinding domain sequences (Ala507-Arg/Lys508-Leu509); and 30 conserved proline and 18 conserved glycine residues, which may contribute to short loop formation within the exoplasmic HDL-binding sequence. Vertebrate SCARB1 genes usually contained 12 coding exons. The human SCARB1 gene contained CpG islands, micro RNA binding sites, and several transcription factor binding sites (including PPARG) which may contribute to the high level (13.7 times the average) of gene expression. Phylogenetic analyses examined the relationships and potential evolutionary origins of the vertebrate SCARB1 gene with vertebrate SCARB2 and vertebrate and invertebrate SCARB3 (CD36) genes. These suggested that SCARB1 originated in a vertebrate ancestral genome from a gene duplication event of an ancestral invertebrate CD36 gene.
Introduction
Scavenger receptor class B type 1 protein (SCARB1, also called CLA1, SRB1, and CD36 L1) is one of at least three members of the type 1 thrombospondin receptor CD36 (cluster of differentiation 36) family that serves as an homo-oligomeric plasma membrane cell surface glycoprotein receptor for high-density (HDL) lipoprotein cholesterol, other phospholipid ligands, and chylomicron remnants. 1-10 SCARB1 has also been implicated in the uptake of hepatitis C virus (HCV) in the liver [11] [12] [13] [14] and in platelet activation. 15 and may also participate in the phagocytosis of apoptotic cells. [16] [17] [18] SCARB2, also called lysosomal integral membrane protein 2, SRB2, and Materials and methods vertebrate SCARB1 gene and protein identification BLAST (Basic Local Alignment Search Tool) studies were undertaken using web tools from the National Center for Biotechnology information site (http://blast.ncbi.nlm.nih. gov/Blast.cgi). 52 Protein BLAST analyses used vertebrate SCARB1 amino acid sequences previously described (Table 1) . Non-redundant protein sequence databases for several mammalian genomes were examined using the BLASTP algorithm, including human (Homo sapiens), 53 chimpanzee (Pan troglodytes), 54 rhesus monkey (Macaca mulatta), 55 cow (Bos taurus), 56 mouse (Mus musculus), 57 rat (Rattus norvegicus), 58 opossum (Monodelphis domestica), 59 platypus (Ornithorhynchus anatinus), 60 chicken (Gallus gallus), 61 lizard (Anolis carolinensis), 62 frog (Xenopus tropicalis), 63 and zebrafish (Danio rerio). 64 This procedure produced multiple BLAST "hits" for each of the protein databases which were individually examined and retained in FASTA format, and a record was kept of the sequences for predicted mRNAs and encoded SCARB1-like proteins. These records were derived from annotated genomic sequences using the gene prediction method, ie, GNOMON and predicted sequences with high similarity scores for human SCARB1. Predicted SCARB1-like protein sequences were obtained in each case and subjected to analyses of predicted protein and gene structures.
BLAT (Blast Like Alignment Tool) analyses were subsequently undertaken for each of the predicted SCARB1 amino acid sequences using the UC Santa Cruz Genome Browser 65 with default settings to obtain the predicted locations for each of the vertebrate SCARB1 genes, including predicted exon boundary locations and gene sizes. BLAT analyses were similarly undertaken for other vertebrate SCARB1, SCARB2, and SCARB3 (CD36) genes using previously reported sequences in each case (see Table 1 ). Structures for human and mouse isoforms (splicing variants) were obtained using the AceView website to examine predicted gene and protein structures. 31 Predicted structures and properties of vertebrate SCARB1 examined for comparative gene expression levels among human and mouse tissues showing high (red), intermediate (black) , and low (green) expression levels.
Phylogeny studies and sequence divergence
Alignments of vertebrate SCARB1, SCARB2, and SCARB3 sequences were assembled using BioEdit v.5.0.1 and the default settings. 69 Ambiguous alignment regions, including the amino and carboxyl termini, were excluded prior to phylogenetic analysis, yielding alignments of 431 residues for comparisons of vertebrate SCARB1 sequences with human, mouse, chicken, and zebrafish SCARB2 and SCARB3 sequences with the lancelet (Branchiostoma floridae) CD36 sequence ( Table 1) . Evolutionary distances were calculated using the Kimura option 70 in TREECON. 71 Phylogenetic trees were constructed from evolutionary distances using the neighborjoining method 72 and rooted with the seasquirt CD36 sequence. Tree topology was reexamined by the boot-strap method (100 bootstraps were applied) of resampling, and only values that were highly significant ($95) are shown. 73
Results and discussion

Alignments of vertebrate SCARB1 amino acid sequences
The deduced amino acid sequences for pig (Sus scrofa), opossum (M. domestica), platypus (O. anatinus), and frog (X. tropicalis) SCARB1 are shown in Figure 1 , together with previously reported sequences for human, 74 mouse, 75 and cow SCARB1 ( Table 1) . 47 Alignments of human with other vertebrate SCARB1 sequences examined were between 50% and 99% identical, suggesting that these are products of the same family of genes, whereas comparisons of sequence identities of vertebrate SCARB1 proteins with human SCARB2 and SCARB3 proteins exhibited lower levels of sequence identities of 30%-33% and 30%-32%, respectively, indicating that these are members of distinct SCARB or CD36-like gene families ( Table 1) .
The amino acid sequences for mammalian SCARB1 contained 509 residues whereas frog (X. tropicalis) SCARB1 sequences contained 505 amino acids ( Figure 1 ). Previous studies have reported several key regions and residues for human and mouse SCARB1 proteins (human SCARB1 amino acid residues were identified in each case). These included: cytoplasmic N-terminal and C-terminal residues 2-11 and 461-509; N-terminal and C-terminal transmembrane helical regions, ie, residues 12-33 and 441-460; 8, 46, 74 key N-terminal glycine residues (Gly15/Gly18/Gly25) which form a dimerization motif in the N-terminal transmembrane domain and participate in forming SCARB1 oligomers; 76 a C-terminal PDZK1-interacting domain previously identified for the last three amino acids of SCARB1, ie, Ala-Lys-Leu; 75 exoplasmic Cys384, where a free SH group plays a major role in SCARB1-mediated lipid transport; four exoplasmic disulfide bond-forming residues, ie, Cys280, Cys321, Cys323, and Cys334; 77, 78 and 10 exoplasmic N-glycosylation sites for human SCARB1, which have been identified or predicted for this protein (Table 2 ). 79 One of these sites (site 1) contained a proline residue at the second position and may not function as an N-glycosylation site due to proline-induced inaccessibility. 67 Eight of these sites were predominantly retained among the 19 vertebrate SCARB1 sequences examined (sites 2-3 and 6-12 in Table 2 ), whereas rat and mouse SCARB1 sequences contained an additional N-glycosylation site at 116 Asn-117 Arg-118Ser, and chicken, lizard, and salmon SCARB1 sequences contained a further site at 125 Asn-126Gly-127Thr ( Figure 1 , Table 2 ). Given the sequence conservation observed for these residues among the vertebrate SCARB1 sequences examined, it is apparent that they are essential for the structure and function of a glycoprotein. The multiple N-glycosylation sites observed for vertebrate SCARB1 sequences support a major role for glycan residues exposed on the external surface of plasma membranes in the performance of SCARB1 functions in binding various lipoproteins, including HDL, and in cholesterol transfer, as part of the reverse cholesterol transport role proposed for SCARB1. 79 
Conserved glycines in N-terminal oligomerization domain of the transmembrane sequence
The N-terminal region for vertebrate SCARB1 sequences (residues 1-42 for human SCARB1) contained cytoplasmic (residues 2-11) and transmembrane (residues 12-33) motifs which underwent changes in amino acid sequence but retained the predicted cytoplasmic and transmembrane properties in each case (Figure 1, Supplementary Figure 1 ). Vertebrate N-terminal transmembrane sequences in particular were predominantly conserved, especially for Gly15, Gly18, and Gly25 SCARB1 residues, which were fully conserved among all mammalian and frog SCARB1 sequences examined (Figure 1, Supplementary Figure 1 ). However, other lower vertebrate SCARB1 sequences, such as lizard and zebrafish SCARB1 sequences, contained a replacement at the Gly15 position (Ala15 and Leu12, respectively, data not shown). Additional glycine residues were observed in this region for some vertebrate SCARB1 sequences, including consecutive submit your manuscript | www.dovepress.com
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vertebrate SCARB1: comparative studies and evolution Research and Reports in Biochemistry downloaded from https://www.dovepress.com/ by 54.70.40.11 on 06-Dec-2018 For personal use only. glycines for opossum SCARB1 (residues 25 and 26, Figure 1 ) and for chicken (residues 23 and 24) and zebrafish (residues 15 and 16) SCARB1 sequences (sequences not shown). Sitedirected mutagenesis studies have demonstrated key roles for the Gly15-(X) 2 -Gly18-(X) 5 -Gly25 motif within the N-terminus transmembrane sequence, by facilitating oligomerization and selective lipid uptake by SCARB1, particularly for the Gly18 and Gly25 residues. 76 A conserved glycine residue was also observed for the mammalian and frog C-terminal transmembrane sequences (human SCARB1 Gly451, Figure 1 , Supplementary Figure 1 ), but it is not known whether or not this glycine has a similar role to that of the conserved N-terminal transmembrane glycine residues.
Conservation of cytoplasmic C-terminal PDZK1-interacting domain
The cytoplasmic C-terminal region of SCARB1, particularly the last three amino acids of mouse SCARB1, ie, Ala507-Lys508-Leu509, has been shown to interact with a PDZ domain-containing protein (PDZK1) which has been suggested to be responsible for the cell surface expression of this protein. 75 to be abundant protein interaction motifs which function in regulating biological processes such as transport (in this case, lipid transport), ion channel signaling, and other signal transduction systems. 82, 83 Comparisons of mammalian SCARB1 cytoplasmic C-terminal sequences ( Supplementary Figure 1 ) support a high level of conservation for the last three amino acids, with a consensus sequence of Ala507-Lys/Arg508-Leu509 being maintained. This conservation extends further into the protein as follows: Gly501-Thr, Ser or Ala502-Val503-Leu504-Gln505-Glu506, which may also contribute to PDZK1 binding.
Conserved cysteine residues within the exoplasmic domain
Five cysteine residues of the mammalian and frog SCARB1 exoplasmic sequences (residues 34-440 for human SCARB1) were conserved among the proteins examined, of which four participate in disulfide bridge formation (cys281, cys321, cys323, and cys334), and the fifth (cys384) plays an essential role (via the free SH group) in lipid transport. 77 demonstrated no significant involvement of this exoplasmic SH group in lipid transfer activity. 77 Moreover, the Cys251 residue has been substituted in the frog SCARB1 sequence by threonine, supporting the view that it is not an essential amino acid for vertebrate SCARB1 at this position ( Figure 1 ).
Predicted secondary structures for vertebrate SCARB1
Predicted secondary structures for mammalian and frog SCARB1 sequences were examined (Figure 1) , particularly for the exoplasmic sequences. α-helix and β-sheet structures were similar in each case, with an α-helix extending beyond the N-terminal and C-terminal transmembrane regions: α1 and α7. A consistent sequence of predicted secondary structure was observed for each of mammalian and frog SCARB1 sequences:
Further description of the secondary and tertiary structures for SCARB1 must await the three-dimensional structure for this protein, particularly for the exoplasmic region which directly binds HDL and participates in reverse cholesterol transport.
Conserved proline and glycine residues within the SCARB1 exoplasmic domain Figure 2 shows the alignment of 15 vertebrate SCARB1 amino acid sequences for the exoplasmic domain, with colors depicting the properties of individual amino acids and the strong conservation observed for these protein sequences. In addition to the key vertebrate SCARB1 amino acids detailed previously, others are also conserved, including 30 proline residues. Prolines play a major role in protein folding and protein-protein interactions involving the cyclic pyrrolidine Table 1 for sources of SCARB1 sequences. *Identical residues for SCARB1 subunits; similar alternate residues; dissimilar alternate residues; predicted cytoplasmic residues are shown in red; predicted transmembrane residues are shown in blue; N-glycosylated and potential N-glycosylated Asn sites are shown in green; free SH Cys involved in lipid transfer is shown in pink; predicted disulfide bond Cys residues are shown in blue; predicted α-helices for vertebrate SCARB1 are shown in yellow and numbered in sequence from the start of the predicted exoplasmic domain; predicted β-sheets are shown in gray and also numbered in sequence; bold underlined font shows residues corresponding to known or predicted exon start sites; exon numbers refer to human SCARB1 gene exons. **Final three C-terminal residues which bind a PDZ domain-containing protein (PDZK1); G residues are conserved glycines in the N-terminal oligomerization domain of the transmembrane sequence. amino acid side chain, which may introduce turns (or kinks) in the polypeptide chain as well as having destabilizing effects on α-helix and β-strand conformations. 84 In addition, the presence of sequential prolines within a protein sequence may confer further restriction in folding conformation and create a distinctive structure, such as that reported for the mammalian Na + /H + exchanger, which plays a major role in cation transport. 85 Sequential prolines (Pro317-Pro318) were conserved for all vertebrate SCARB1 sequences examined and may confer a distinctive conformation in this region, supporting the lipid transfer functions for this protein (Figure 2 ). Moreover, regions of water-exposed proteins with high levels of proline residues are often sites for protein-protein interactions 86 and these residues may play essential roles in the binding of HDL and other lipoproteins by the exoplasmic region of SCARB1. Figure 2 also shows conservation of 18 glycine residues for these vertebrate SCARB1 exoplasmic domains which, due to their small size, may be essential for static turns, bends, or close packing in the domain, or required for conformational dynamics during HDL receptor on-off switching, as in the case of the aspartate receptor protein. 87 Both proline and glycine residues are frequently found in turn and loop structures of proteins, and usually influence short loop formation within proteins containing 2-10 amino acids. 88 Evidence for these short loop structures within SCARB1 exoplasmic sequences was evident from the predicted secondary structures for vertebrate SCARB1 (see Figure 1 ) with proline and/or glycine residues found at the start of the following structures: α1 (Pro33), β1 (Pro62), α2 (Pro75), β2 (Pro84), β3 (Gly90-Pro91), α3 (Pro136), α4 (Pro152), α5 (Pro186), β7 (Gly206), β10 (Pro277), β11 (296Gly, 298Pro), β12 (Gly327), α6 (Pro352), β14 (Gly379, Pro381), β15 (Pro408), and α7 (Gly424). Moreover, conserved SCARB1 sequential proline residues (Pro315-Pro316) are located in a region with no predicted secondary structure (between β11 and β12) but submit your manuscript | www.dovepress.com
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Figure 3
Amino acid sequence alignments for mouse SCARB1, SCARB2, and SCARB3 (CD36) sequences. Notes: See Table 1 for sources of mouse SCARB1, SCARB2, and SCARB3 (CD36) sequences. *Identical residues for SCARB1 subunits; similar alternate residues; dissimilar alternate residues; predicted cytoplasmic residues are shown in red; predicted transmembrane residues are shown in blue; N-glycosylated and potential N-glycosylated Asn sites are in green; free SH Cys involved in lipid transfer is shown in pink; predicted disulfide bond Cys residues are shown in blue; predicted α-helices for vertebrate SCARB1 are in shaded yellow and numbered in sequence from the start of the predicted exoplasmic domain; predicted β-sheets are in shaded gray and also numbered in sequence; bold underlined font shows residues corresponding to known or predicted exon start sites; exon numbers are shown; ***Final three C-terminal residues which bind a PDZ domain-containing protein (PDZK1) for mouse SCARB1. Abbreviation: SCARB, scavenger receptor class B.
with disulfide bonds present, 77 which suggests that this is a region of conformational significance for SCARB1.
Alignments of mouse SCARB1, SCARB2, and SCARB3 (CD36) amino acid sequences
The amino acid sequences for mouse SCARB1, SCARB2, and SCARB3 (see Table 1 ) are aligned in Figure 3 . The sequences were 30%-33% identical and showed similarities in several key features and residues, including: cytoplasmic N-terminal and C-terminal residues; N-terminal and C-terminal transmembrane helical regions; exoplasmic disulfide bond forming residues, previously identified for mouse SCARB3 (CD36): Cys243, Cys272, Cys311, Cys313, Cys322, and Cys333; 77 several predicted N-glycosylation sites for mouse SCARB1 (11 sites), SCARB2 (11 sites), and SCARB3 (7 sites), of which two are shared between these sequences (N-glycosylation sites 7 and 9 (Table 2)); and similar predicted secondary structures previously identified for SCARB1 ( Figure 1) . The free SH group Cys384 residue, which plays a major role in SCARB1-mediated lipid transport, 77 was unique for SCARB1, being replaced by other residues for the corresponding SCARB2 and SCARB3 proteins. N-terminal transmembrane glycine residues, which play a role in the formation of SCARB1 oligomers, 76 were also observed for the corresponding mouse SCARB3 (CD36) sequence, although only one of these glycines (Gly10) was retained for the mouse SCARB2 sequence. These results suggest that mouse SCARB1, SCARB2, and SCARB3 proteins share several important properties, features, and conserved residues, including being membrane-bound with cytoplasmic and transmembrane regions, and have similar secondary structures, but are sufficiently different to serve distinct functions. 
Figure 4
Gene structures and major splicing transcripts for the human and mouse SCARB1 genes. Notes: Derived from the Aceview website (http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/) 31 mature isoform variants are shown with capped 5′ and 3′ ends for the predicted mRNA sequences; NM refers to the National Center for Biotechnology Information reference sequence; exons are in pink; the directions for transcription are shown as 5′ → 3′; black squares show predicted CpG island sites at or near the 5′ untranslated regions of the genes; the symbol ∧ shows predicted microRNA binding sites observed at or near the SCARB1 3' untranslated regions; sizes of mRNA sequences are shown in kilobases; predicted transcription factor binding sites for human SCARB1 are shown as stars. Abbreviations: SCARB1, scavenger receptor class B type 1 protein; STAT1, signal transducer and activator of transcription; FOXL1, forkhead related transcription factor; HSF1, heat shock transcription factor; RFX1, MHC class II regulatory factor; SOX9, transcription factor; PPARG, peroxisome proliferator-activated receptor γ; SCARB1, scavenger receptor class B type 1. Table 1 summarizes the predicted locations for vertebrate SCARB1 genes based upon BLAT interrogations of several vertebrate genomes using the reported sequences for human, 43, 44 mouse, 45 rat, 46 cow, 47 and salmon 48 and the predicted sequences for other vertebrate SCARB1 genes and the UC Santa Cruz genome browser. 65 The predicted vertebrate SCARB1 genes were transcribed on either the negative strand (primate, mouse, rabbit, platypus, frog, and zebrafish genomes) or the positive strand (rat, guinea pig, cow, dog, pig, opossum, chicken, and lizard genomes). Figure 1 summarizes the predicted exonic start sites for human, mouse, cow, opossum, platypus, and frog SCARB1 genes, with each having 12 coding exons in identical or similar positions to those predicted for the human SCARB1 gene. 43, 44 Figure 4 shows the predicted structures of mRNAs for the three major human SCARB1 transcripts and the major Scarb1 transcript. 31 The human transcripts were 2.6-2.7 kilobases in length, with 12 (isoforms a and c) or 13 (isoform b) introns present for these SCARB1 mRNA transcripts, and in each case, an extended 3′-untranslated region was observed. The human SCARB1 genome sequence contained several predicted transcription factor binding sites, three microRNA binding sites (miR-125/351, miR-223, and miR-145) located in the 3′-untranslated region and three CpG islands (CpG78, CpG24, and CpG27), of which CpG78 is located in the 5′-untranslated promoter region of human SCARB1 on chromosome 12. Mouse Scarb1 also contains a CpG island within the gene promoter (CpG33) as well as two of the human predicted microRNA target sites (miR145 and miR125/351) within the mouse Scarb1 3′-untranslated region. The SCARB1 CpG islands residing proximate to the promoter may contribute to the very high level of gene expression (13.7 times for human SCARB1 and 5.1 times the average gene expression for mouse Scarb1) 31 and may be submit your manuscript | www.dovepress.com
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compared with the CpG islands within housekeeping gene promoters expressed in most tissues. 89 Of particular significance among the transcription factor binding sites observed is the peroxisome proliferator-activated receptor-γ site, which has been shown to stimulate liver SCARB1 expression 90 and to participate in regulating cholesterol uptake and efflux from macrophages, and to promote uptake of oxidized low-density lipoproteins and subsequent differentiation of monocytes into foam cells. [91] [92] [93] The prediction of multiple miRNA target sites within the 3′-untranslated regions of human SCARB1 and mouse Scarb1 is also potentially of major significance because of the role that small noncoding RNAs play in regulating mRNA and protein expression during embryonic development. 94 Comparative human and mouse SCARB1 tissue expression Figure 5 presents "heat maps" showing comparative gene expression for various human and mouse tissues obtained from GNF Expression Atlas Data using the U133 A and GNF1H (human) and GNF1M (mouse) chips (http://genome. ucsc.edu; http://biogps.gnf.org). 68 These data supported a broad and high level of tissue expression for human and mouse SCARB1, particularly for the adrenal gland, liver, lymphocytes, ovary and placenta, which is consistent with previous reports for these genes. 1, 8, 47, 74 Overall however, human and mouse SCARB1 tissue expression levels were 3-4 times the average level of gene expression, which supports the key role played by this enzyme in lipid metabolism, especially in the liver, adrenal glands, and lymphocytes, and during embryonic development (http://www.ncbi.nlm.nih. gov/IEB/Research/Acembly/). 31 Phylogeny and divergence of SCARB1 and other vertebrate CD36-like sequences A phylogenetic tree ( Figure 6) sequences with human, mouse, chicken, and zebrafish SCARB2 and SCARB3 (CD36) sequences, which was "rooted" with the lancelet (B. floridae) CD36 sequence (see Table 1 ). The phylogram showed clustering of the SCARB1 sequences into groups, which was consistent with their evolutionary relatedness as well as groups for human, mouse, chicken, and zebrafish SCARB2 and SCARB3 (CD36) sequences, which was distinct from the lancelet CD36 sequence. These groups were significantly different from each other (with bootstrap values of about 100/100). This is suggestive of a sequence of CD36-like gene duplication events: ancestral CD36 (SCARB3) gene duplication → SCARB1 and CD36 genes; followed by a further CD36 duplication, generating the SCARB2 and CD36 genes found in all vertebrate species examined ( Figure 6 ). It is apparent from this study of vertebrate CD-like genes and proteins that this is an ancient protein for which a proposed common ancestor for the SCARB1, SCARB2, and SCARB3 (CD36) genes may have predated the appearance of fish more than 500 million years ago. 95 
Conclusion
The results of the present study indicate that vertebrate SCARB1 genes and encoded proteins represent a distinct gene and protein family of CD36-like proteins which share key conserved sequences that have been reported for other CD36-like proteins (SCARB2 and SCARB3 [CD36]) previously studied. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] SCARB1 has a unique property among these proteins in serving as a major receptor for HDL in the body and participating in reverse cholesterol transport. 10, 33, 46, 49 HDL binding to SCARB1 stimulates endothelial nitric oxide synthase activity, apparently by increasing intracellular ceramide levels, which leads to cholesterol transfer from HDL into the target cell. 4, 96 SCARB1 has also been implicated in the remodeling of large lipoprotein particles by endothelial lipase during SCARB1mediated uptake of HDL cholesterol. 97 SCARB1 is encoded by a single gene among the vertebrate genomes studied and is highly expressed in human and mouse tissues, particularly in adrenal glands, liver, lymphocytes, and embryonic tissues, and usually contains 12 coding exons. Predicted secondary Phylogenetic tree of vertebrate SCARB1 amino acid sequences with human, mouse, chicken, and zebrafish SCARB2 and SCARB3 (CD36) sequences. Notes: The tree is labeled with the SCARB-like name and the name of the animal and is "rooted" with the lancelet CD36 sequence. Note the three major clusters corresponding to the SCARB1, SCARB2, and SCARB3 (CD36) gene families. A genetic distance scale is shown. The number of times a clade (sequences common to a node or branch) occurred in the bootstrap replicates are shown. Only replicate values of 95 or more, which are highly significant, are shown, with 100 bootstrap replicates performed in each case. A proposed sequence of CD36 gene duplication events is shown. Abbreviation: SCARB, scavenger receptor class B. structures for vertebrate SCARB1 proteins show strong similarities with other CD36-like proteins, SCARB2 and SCARB3 (or CD36). Three major structural domains were apparent for vertebrate SCARB1, including the N-terminal and C-terminal cytoplasmic domain, the N-terminal and C-terminal transmembrane domain, and the exoplasmic domain, containing the "lipid-transfer active" free SH Cys384, two disulfide bridges, and several N-glycosylation sites for glycan binding. Phylogenetic studies using 19 vertebrate SCARB1 sequences with human, mouse, chicken, and zebrafish SCARB2 and SCARB3 (CD36) sequences indicated that the SCARB1 gene has appeared early in vertebrate evolution following a gene duplication event of the ancestral CD36 (SCARB3) gene, prior to the appearance of bony fish, more that 500 million years ago.
